Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • AUD/USD

    0.6506
    +0.0017 (+0.26%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.98
    -0.38 (-0.46%)
     
  • GOLD

    2,328.00
    -14.10 (-0.60%)
     
  • Bitcoin AUD

    102,482.23
    +1,003.97 (+0.99%)
     
  • CMC Crypto 200

    1,438.54
    +14.44 (+1.01%)
     

Stocks - Chewy, Altria Fall in Premarket; Stitch Fix, Autozone Rise

Investing.com -- Stocks in focus in premarket trade on Tuesday, 10th December.

Chewy (NYSE:CHWY) stock fell 2.4% after reporting a larger-than-expected loss per share of 20c, compared to expectations of 16c, in its quarterly report after the close on Monday.

Stitch Fix (NASDAQ:SFIX) stock rose 11% after the company defied expectations of a loss in the three months to November in earnings released after the close on Monday. The online personal-styling service also announced the appointment of Bain & Co. digital guru Elizabeth Spaulding as president.

AutoZone (NYSE:AZO) stock rose 5.7% in response to better-than-expected same-store sales in the three months to November.

ADVERTISEMENT

Amazon.com (NASDAQ:AMZN) stock edged 0.4% lower on general concerns about the economy, as the market continued to digest the news of its formal complaint about the way it lost a big-ticket order to provide the Defense Department with cloud-computing services.

Sanofi (PA:SASY) (NASDAQ:SNY) rose 4.5% after the company said it would drop expensive research into diabetes and cardiovascular drugs and squeeze some $2.2 billion a year in cost savings out of its supply chain.

Altria (NYSE:MO) stock fell 0.3%, extending losses on concerns about the valuation of its stake in Juul. Fellow investor Tiger Global has reportedly written its valuation of Juul down to $19 billion, whereas Altria still has a valuation of $24 billion on its books.

Related Articles

Saudi Arabia stocks lower at close of trade; Tadawul All Share down 0.66%

Stitch Fix Spikes as Analysts See Upside From Direct Buy Program

Britain's Lloyds criticized for mistreating victims of major fraud